aaiPharma Inc announced that William L. Ginna, Jr. has stepped down from his position as Executive Vice President and Chief Financial Officer. The Company has initiated a formal search for a new CFO. Until such time, effective immediately, Gina Gutzeit has been appointed to the position of Interim CFO.
Gutzeit is a senior managing director with FTI Consulting, Inc in their Corporate Finance/Restructuring practice. With over 20 years of experience in operational and financial restructuring and transitional management, she has served as interim CFO in addition to financial advisor to numerous companies during her career.
aaiPharma Inc. is a science-based pharmaceutical company focused on pain management, with corporate headquarters in Wilmington, North Carolina. With more than 24 years of drug development expertise, the Company is focused on developing, acquiring, and marketing branded medicines in its targeted therapeutic areas. aaiPharma's development efforts are focused on developing improved medicines from established molecules through its significant research and development capabilities.